BS-4592R-FITC: CDKN2A PAb, FITC Conjugated | Bioss Antibodies - Bio-Connect

General

Product specifications for - CDKN2A/p16INK4a Polyclonal Antibody, FITC Conjugated

Overview:
Product group:	Antibodies
Category:	Primary Antibodies
Subcategory:	Fluorescent conjugated
Application:	IF(IHC-P)
Application note:	IF(IHC-P)(1:50-200)
Species:	Human
Host:	Rabbit
Target:	CDKN2A
Target description:	cyclin-dependent kinase inhibitor 2A
Clonality:	Polyclonal
Conjugation:	FITC
Isotype:	IgG
Source:	KLH conjugated synthetic peptide derived from human CDKN2A

Properties:
Purity:	Purified by Protein A.
Datasheet:	Datasheet
	Research Use Only
UNSPSC:	12352203
Concentration:	1ug/ul
Form supplied:	Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.
Storage instructions:	2-¦C to 8-¦C

Scientific information:
Scientific info:	Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
Gene ID:	1029
Swiss prot ID:	P42771

Additional information:
Synonyms:	BS-4592R-FITC; ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1; p16-INK4; CDKN2A